| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/16/2010 | CN101735986A Hybridoma cell strain secreting monoclonal antibodies against swine HEV and application thereof |
| 06/16/2010 | CN101735320A Yolk immunoglobulin for preventing and treating cryptosporidiosis andersoni |
| 06/16/2010 | CN101735317A Cathepsin D antigen polypeptide and application thereof as well as detecting kit containing polypeptide |
| 06/16/2010 | CN101735310A Human papilloma virus (HPV) fusion protein, gene, carrier, strain, preparation method and application |
| 06/16/2010 | CN101735309A Iridovirus antigen active polypeptide and application thereof |
| 06/16/2010 | CN101732717A Ttk in diagnosis and as a therapeutic target in cancer |
| 06/16/2010 | CN101732716A Antigen-antibody complex for preventing and/or treating avian influenza |
| 06/16/2010 | CN101732715A LSECtin and application of fusion protein thereof in preparing medicine for suppressing metastasis of cancer cells to liver |
| 06/16/2010 | CN101732714A Manchette binding protein and effects thereof during spermiogenesis |
| 06/16/2010 | CN101732713A NOGO-A resisting antibody and extract of ginkgo biloba for treating cerebral apoplexy |
| 06/16/2010 | CN101732712A NOGO-A resisting antibody and vessel conglutinin inhibitor for treating cerebral apoplexy |
| 06/16/2010 | CN101732711A Preparation of nose-spraying flu immunization pentavalent or multivalent inactivated vaccine and application thereof |
| 06/16/2010 | CN101732710A Foot and mouth disease virus inhibitor and preparation method and application thereof |
| 06/16/2010 | CN101732709A Method for preparing haemorrhagic fever vaccine by culturing primary cells in multilayer culture flask |
| 06/16/2010 | CN101732708A Preparation method of vaccine for epidemic encephalitis B |
| 06/16/2010 | CN101732707A Mercury-free Japanese encephalitis inactivated vaccine composition and application thereof |
| 06/16/2010 | CN101732706A Method for preparing living paratyphoid vaccine for piglets and product thereof |
| 06/16/2010 | CN101732705A Cholera toxin vaccine containing preparation for treating severe intestinal infectious diseases |
| 06/16/2010 | CN101732704A Method for preparing inactivated bivalent vaccine against rabbit hemorrhagic disease and pasteurella multocida disease |
| 06/16/2010 | CN101732703A Composition for antagonizing pyretic effect of endotoxin in vaccine on livestock and application thereof |
| 06/16/2010 | CN101732702A Sturgeon bacterial sepsis syndrome holophagae inactivating vaccine and preparation method thereof |
| 06/16/2010 | CN101732701A Constant filtering method for ultrafiltration of vaccine |
| 06/16/2010 | CN101732348A Application of varicella vaccine inflammation induced rabbit fur extractive in preparing medicaments for treating acute cerebrovascular diseases |
| 06/16/2010 | CN101732333A Medicament for treating cancer |
| 06/16/2010 | CN101307305B Low virulent strain of porcine reproductive and respiratory syndrome virus, immunogenicity immunogenicity material and vaccine |
| 06/16/2010 | CN101084011B Porcine reproductive and respiratory syndrome virus strains and compositions |
| 06/16/2010 | CN101045161B Modulators of P-selectin glycoprotein ligand 1 |
| 06/15/2010 | US7737262 For primates; p42 nucleic acid encoding a p42 polypeptide from the C-terminal processing fragment of Plasmodium falciparum major merozoite surface protein gp195 which hybridizes under high stringency conditions |
| 06/15/2010 | US7737258 Complementary determining regions capable binding to the same antigen as the monoclonal antibody 8H9; inhibit competitive binding; isolated scFv of monoclonal antibody 8H9, antigen, antitumor agents |
| 06/15/2010 | US7737256 anti-HIV action of uPAR-activators or activated uPAR molecules; diagnosis of cancer, AIDS and inflammatory diseases; treatment of septic shock, rheumatoid arthritis, Crohn's disease, and chronic arthritis |
| 06/15/2010 | US7737255 monoclonal antibodies used for analyzing changes in the levels of cancer specific genes in cells, tissues or bodily fluids; medical prognosis |
| 06/15/2010 | US7736873 An isolated nucleic acid molecule comprising a nucleotide sequence which encodes the polypeptide comprising the outer membrane protein antigens of gramnegative bacteria, which can be used to prevent and treat gramnegative bacteria infection in mammals, such as humans; immunology; vaccines |
| 06/15/2010 | US7736847 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics |
| 06/15/2010 | US7736660 contacting a mammalian fecal preparation with polyclonal antibodies specific for Toxocara antigens and detecting the presence or absence of antigens or antibody/antigen complexes; medical diagnosis for infection by nematodes |
| 06/15/2010 | US7736659 Clostridial toxin derivatives and methods for treating pain |
| 06/15/2010 | US7736658 Canine combination vaccines |
| 06/15/2010 | US7736656 Immunogenic compositions and vaccines for Ebola |
| 06/15/2010 | US7736655 Neuroprotectants; angoigenesis inhibitors; transcription factors; host cells |
| 06/15/2010 | US7736654 Proteins, polynucleotides, antibodies, transgenic animals, hybridoma; humoral or cellular immune response; pancreatic |
| 06/15/2010 | US7736653 Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier |
| 06/15/2010 | US7736652 Comprises immunoglobulin-immunostimulant fusion protein for use in preventing and treating infections, cancer and autoimmune disorders; genetic vaccination; gene therapy |
| 06/15/2010 | US7736651 Alpha emitting constructs and uses thereof |
| 06/15/2010 | US7736650 recombinant expression vectors and plasmids comprising restriction sites for cloning antibodies |
| 06/15/2010 | US7736649 preventing the viral entry process into target cells, by inhibiting the binding of viral surface glycoprotein to cell surface CD4, to fusion coreceptors CCR5 chemokine receptors and the transient conformation fusion intermediate that ultimately folds into a conformation capable of mediating fusion |
| 06/15/2010 | US7736648 Anti-RSV G protein antibodies |
| 06/15/2010 | US7736647 an antigen binding fragment comprising a heavy chain and a light chain variable region amino acid sequences, associated to effector cells for triggering antibody-dependent cell-mediated cytotoxicity (ADCC) mechanisms; useful for inhibiting proliferation and/or killing melanoma cells |
| 06/15/2010 | US7736646 Methods for modulating angiogenesis with apelin compositions |
| 06/15/2010 | US7736645 inhibiting angiogenesis in tissues expressing a endocrine gland-derived vascular endothelial growth factor(EG-VEGF) polypeptide, comprising contacting the tissue with an antagonist antibody of the EG-VEGF polypeptide or an antigen binding fragment; regulating cellular proliferation and chemotaxis |
| 06/15/2010 | US7736644 Monoclonal antibody for use as tool in treatment and prevention of cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 06/15/2010 | US7736642 Yeast-based vaccine for inducing an immune response |
| 06/15/2010 | US7736640 administering to mammal more than one dose of a composition comprising live Newcastle Disease Virus in an amount sufficient to cause tumor regression |
| 06/15/2010 | CA2410253C Regulating lipid levels via the zmax1 or hbm gene |
| 06/15/2010 | CA2405050C Production of tcr gamma delta t cells |
| 06/15/2010 | CA2404388C New prostate cell lines |
| 06/15/2010 | CA2295940C Epitopes of shigella like toxin and their use as vaccine and in diagnosis |
| 06/15/2010 | CA2250080C Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 06/10/2010 | WO2010065962A2 Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease |
| 06/10/2010 | WO2010065939A1 Combination therapy to enhace nk cell mediated cytotoxicty |
| 06/10/2010 | WO2010065920A1 Compositions and methods for the treatment and prevention of lens fibrotic diseases |
| 06/10/2010 | WO2010065882A1 Dual variable domain immunoglobulins and uses thereof |
| 06/10/2010 | WO2010065819A1 Method for the treatment of neurodegenerative diseases |
| 06/10/2010 | WO2010065613A2 Annexina2 as immunological target |
| 06/10/2010 | WO2010065578A2 POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME |
| 06/10/2010 | WO2010065496A1 Anti-ferroportin 1 monoclonal antibodies and uses thereof |
| 06/10/2010 | WO2010065437A1 Modulation of olfml-3 mediated angiogenesis |
| 06/10/2010 | WO2010065414A1 Use of micrornas to control virus helper nucleic acids |
| 06/10/2010 | WO2010065400A1 Cancer biomarker and methods of using thereof |
| 06/10/2010 | WO2010065293A1 Antibodies for guanylyl cyclase receptors |
| 06/10/2010 | WO2010065159A1 Inhibition of dna polymerases to augment chemotherapeutic and antimicrobial agents |
| 06/10/2010 | WO2010065140A2 Recombinant raccoon pox virus vaccine against highly pathogenic avian influenza |
| 06/10/2010 | WO2010065079A2 Antibodies to il-6 and use thereof |
| 06/10/2010 | WO2010065078A1 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue and/or fever |
| 06/10/2010 | WO2010065077A2 Antagonists of il-6 to prevent or treat thrombosis |
| 06/10/2010 | WO2010065072A1 Antagonists of il-6 to raise albumin and/or lower crp |
| 06/10/2010 | WO2010064736A1 Therapeutic agent for cancer |
| 06/10/2010 | WO2010064697A1 Anti-nr10 antibody, and use thereof |
| 06/10/2010 | WO2010064456A1 Anti-nr10 antibodies and utilization of the same |
| 06/10/2010 | WO2010064430A1 Wdrpuh epitope peptides and vaccines containing the same |
| 06/10/2010 | WO2010064243A1 GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS |
| 06/10/2010 | WO2010064241A1 Subcutaneous administration of anti-hepatitis b antibodies |
| 06/10/2010 | WO2010064208A2 Msp2 antigenic peptides and their use |
| 06/10/2010 | WO2010064204A2 Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof |
| 06/10/2010 | WO2010064164A1 Bovine viral diarrhea virus with a modified erns protein |
| 06/10/2010 | WO2010064090A1 Process for the modulation of the antagonistic activity of a monoclonal antibody |
| 06/10/2010 | WO2010064089A1 Novel anti-cmet antibody |
| 06/10/2010 | WO2010064012A2 Treatment |
| 06/10/2010 | WO2010063746A1 Process for the modulation of the antagonistic activity of a monoclonal antibody |
| 06/10/2010 | WO2010063693A1 Process for production of vaccines |
| 06/10/2010 | WO2010063685A1 Vaccine |
| 06/10/2010 | WO2010063675A1 Fully human influenza m2 specific antibodies |
| 06/10/2010 | WO2010063488A1 Il-3 inhibitors in use for treatment of rheumatoid arthritis in an early stage |
| 06/10/2010 | WO2010063138A1 A monoclonal antibody specifically binding to vegf and the hybridoma secreting same and uses thereof |
| 06/10/2010 | WO2010063113A1 Anti-cobra toxin antibody fragments and method of producing a vhh library |
| 06/10/2010 | WO2010028072A3 Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use |
| 06/10/2010 | WO2010027736A3 Antimicrobial protein compositions and production therefor from marine bacteria |
| 06/10/2010 | WO2010019954A3 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs |
| 06/10/2010 | WO2010019702A3 Ddr1-binding agents and methods of use thereof |
| 06/10/2010 | WO2010017209A9 Membrane proximal region of hiv gp41 anchored to the lipid layer of a virus-like particle vaccine |
| 06/10/2010 | WO2010011331A3 Compositions and methods related to sirt1 function |
| 06/10/2010 | WO2009149443A3 A metal-citrate transporter antigen from streptomyces coelicolor and uses thereof |